Evaluation of Safety, Efficacy and Thermogenesis-induction of RZL-012 in Overweight and Obese Volunteers
Clinical trial NCT03171415 · COMPLETED
Trial details
- NCT number
- NCT03171415
- Sponsor
- Raziel Therapeutics Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-25
- Primary completion
- 2018-12-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.